1. Home
  2. MNKD vs NYAX Comparison

MNKD vs NYAX Comparison

Compare MNKD & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • NYAX
  • Stock Information
  • Founded
  • MNKD 1991
  • NYAX 2005
  • Country
  • MNKD United States
  • NYAX Israel
  • Employees
  • MNKD N/A
  • NYAX N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • NYAX
  • Sector
  • MNKD Health Care
  • NYAX
  • Exchange
  • MNKD Nasdaq
  • NYAX Nasdaq
  • Market Cap
  • MNKD 1.7B
  • NYAX 1.8B
  • IPO Year
  • MNKD 2004
  • NYAX N/A
  • Fundamental
  • Price
  • MNKD $5.33
  • NYAX $43.00
  • Analyst Decision
  • MNKD Strong Buy
  • NYAX Buy
  • Analyst Count
  • MNKD 5
  • NYAX 5
  • Target Price
  • MNKD $10.80
  • NYAX $46.67
  • AVG Volume (30 Days)
  • MNKD 4.4M
  • NYAX 8.1K
  • Earning Date
  • MNKD 11-05-2025
  • NYAX 11-11-2025
  • Dividend Yield
  • MNKD N/A
  • NYAX N/A
  • EPS Growth
  • MNKD 149.32
  • NYAX N/A
  • EPS
  • MNKD 0.11
  • NYAX 0.57
  • Revenue
  • MNKD $301,736,000.00
  • NYAX $348,663,000.00
  • Revenue This Year
  • MNKD $14.78
  • NYAX $31.84
  • Revenue Next Year
  • MNKD $19.36
  • NYAX $22.85
  • P/E Ratio
  • MNKD $50.09
  • NYAX $74.80
  • Revenue Growth
  • MNKD 21.48
  • NYAX 29.63
  • 52 Week Low
  • MNKD $3.38
  • NYAX $25.32
  • 52 Week High
  • MNKD $7.63
  • NYAX $52.46
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 49.48
  • NYAX 29.90
  • Support Level
  • MNKD $5.28
  • NYAX $43.73
  • Resistance Level
  • MNKD $5.62
  • NYAX $44.70
  • Average True Range (ATR)
  • MNKD 0.24
  • NYAX 0.80
  • MACD
  • MNKD -0.02
  • NYAX -0.52
  • Stochastic Oscillator
  • MNKD 58.80
  • NYAX 0.00

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

Share on Social Networks: